4,492
Views
7
CrossRef citations to date
0
Altmetric
Review Article

Molecular diagnostics of disorders of sexual development: an Indian survey and systems biology perspective

ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 105-120 | Received 01 May 2018, Accepted 11 Nov 2018, Published online: 14 Dec 2018

References

  • Abilash VG, Radha S, Marimuthu KM, Thangaraj K, Arun S, Nishu S, Meena J, Anuradha D. 2016. Clinical, cytogenetic and molecular analysis of androgen insensitivity syndromes from south Indian cohort and detection and in-silico characterization of androgen receptor gene mutations. Clin Chim Acta. 453:123–130.
  • Adamovic T, Nordenskjold A. 2012. The CAG repeat polymorphism in the androgen receptor gene modifies the risk for hypospadias in Caucasians. BMC Med Genet. 13:109.
  • Akcay T, Fernandez-Cancio M, Turan S, Guran T, Audi L, Bereket A. 2014. AR and SRD5A2 gene mutations in a series of 51 Turkish 46,XY DSD children with a clinical diagnosis of androgen insensitivity. Andrology. 2(4):572–578.
  • Akella RR. 2017. Mutational analysis of androgen receptor gene in two families with androgen insensitivity. Indian J Endocrinol Metab. 21(4):520–523.
  • Al Kandari H, Katsumata N, Alexander S, Rasoul MA. 2006. Homozygous mutation of P450 side-chain cleavage enzyme gene (CYP11A1) in 46, XY patient with adrenal insufficiency, complete sex reversal, and agenesis of corpus callosum. J Clin Endocrinol Metab. 91(8):2821–2826.
  • Albers N, Ulrichs C, Gluer S, Hiort O, Sinnecker GH, Mildenberger H, Brodehl J. 1997. Etiologic classification of severe hypospadias: implications for prognosis and management. J Pediatr. 131(3):386–392.
  • Amberger JS, Bocchini CA, Schiettecatte F, Scott AF, Hamosh A. 2015. OMIM.org: online Mendelian Inheritance in Man (OMIM(R)), an online catalog of human genes and genetic disorders. Nucleic Acids Res. 43(Database issue):D789–798.
  • Andersson S, Berman DM, Jenkins EP, Russell DW. 1991. Deletion of steroid 5 alpha-reductase 2 gene in male pseudohermaphroditism. Nature. 354(6349):159–161.
  • Auchus RJ, Miller WL. 2012. Defects in androgen biosynthesis causing 46,XY disorders of sexual development. Semin Reprod Med. 30(5):417–426.
  • Bashamboo A, Rahman MM, Prasad A, Chandy SP, Ahmad J, Ali S. 2005. Fate of SRY, PABY, DYS1, DYZ3 and DYZ1 loci in Indian patients harbouring sex chromosomal anomalies. Mol Hum Reprod. 11(2):117–127.
  • Bertelloni S, Scaramuzzo RT, Parrini D, Baldinotti F, Tumini S, Ghirri P. 2007. Early diagnosis of 5alpha-reductase deficiency in newborns. Sex Dev. 1(3):147–151.
  • Brinkmann AO. 2001. Molecular basis of androgen insensitivity. Mol Cell Endocrinol. 179(1–2):105–109.
  • Bruggenwirth HT, Boehmer AL, Verleun-Mooijman MC, Hoogenboezem T, Kleijer WJ, Otten BJ, Trapman J, Brinkmann AO. 1996. Molecular basis of androgen insensitivity. J Steroid Biochem Mol Biol. 58(5–6):569–575.
  • Caldarola G, Battista C, Pellicano R. 2010. Melanoma onset after estrogen, thyroid, and growth hormone replacement therapy. Clin Ther. 32(1):57–59.
  • Carmichael SL, Witte JS, Ma C, Lammer EJ, Shaw GM. 2014. Hypospadias and variants in genes related to sex hormone biosynthesis and metabolism. Andrology. 2(1):130–137.
  • Chauhan V, Jyotsna VP, Jain V, Khadgawat R, Dada R. 2017. Novel heterozygous genetic variants in patients with 46,XY gonadal dysgenesis. Horm Metab Res. 49(1):36–42.
  • Choi JH, Kim GH, Seo EJ, Kim KS, Kim SH, Yoo HW. 2008. Molecular analysis of the AR and SRD5A2 genes in patients with 46,XY disorders of sex development. J Pediatr Endocrinol Metab. 21(6):545–553.
  • Codner E, Okuma C, Iniguez G, Boric MA, Avila A, Johnson MC, Cassorla FG. 2004. Molecular study of the 3 beta-hydroxysteroid dehydrogenase gene type II in patients with hypospadias. J Clin Endocrinol Metab. 89(2):957–964.
  • Cong P, Ye Y, Wang Y, Lu L, Yong J, Yu P, Joseph KK, Jin F, Qi M. 2012. A large deletion/insertion-induced frameshift mutation of the androgen receptor gene in a family with a familial complete androgen insensitivity syndrome. Gene. 500(2):220–223.
  • Cooke MW, Ferner RE. 1993. Chemical burns causing systemic toxicity. Arch Emerg Med. 10(4):368–371.
  • Das DK, Rahate SG, Mehta BP, Gawde HM, Tamhankar PM. 2013. Mutation analysis of mitogen activated protein kinase 1 gene in Indian cases of 46,XY disorder of sex development. Indian J Hum Genet. 19(4):437–442.
  • Das DK, Sanghavi D, Gawde H, Idicula-Thomas S, Vasudevan L. 2011. Novel homozygous mutations in desert hedgehog gene in patients with 46,XY complete gonadal dysgenesis and prediction of its structural and functional implications by computational methods. Eur J Med Genet. 54(6):e529–534.
  • de Mateo S, Castillo J, Estanyol JM, Ballesca JL, Oliva R. 2011. Proteomic characterization of the human sperm nucleus. Proteomics. 11(13):2714–2726.
  • Deeb A, Jaaskelainen J, Dattani M, Whitaker HC, Costigan C, Hughes IA. 2008. A novel mutation in the human androgen receptor suggests a regulatory role for the hinge region in amino-terminal and carboxy-terminal interactions. J Clin Endocrinol Metab. 93(10):3691–3696.
  • Diaz FJ, Anthony K, Halfhill AN. 2011. Early avian follicular development is characterized by changes in transcripts involved in steroidogenesis, paracrine signaling and transcription. Mol Reprod Dev. 78(3):212–223.
  • Eggers S, Ohnesorg T, Sinclair A. 2014. Genetic regulation of mammalian gonad development. Nat Rev Endocrinol. 10(11):673–683.
  • Eggers S, Sadedin S, van Den Bergen JA, Robevska G, Ohnesorg T, Hewitt J, Lambeth L, Bouty A, Knarston IM, Tan TY, et al. 2016. Disorders of sex development: insights from targeted gene sequencing of a large international patient cohort. Genome Biol. 17(1):243.
  • Eunice M, Philibert P, Kulshreshtha B, Audran F, Paris F, Khurana ML, Pulikkanath PE, Kucheria K, Sultan C, Ammini AC. 2008. Molecular diagnosis of 5alpha-reductase-2 gene mutation in two Indian families with male pseudohermaphroditism. Asian J Androl.. 10(5):815–818.
  • Fareed M, Kaisar Ahmad M, Azeem Anwar M, Afzal M. 2017. Impact of consanguineous marriages and degrees of inbreeding on fertility, child mortality, secondary sex ratio, selection intensity, and genetic load: a cross-sectional study from Northern India. Pediatr Res. 81(1–1):18–26.
  • Fisher CR, Graves KH, Parlow AF, Simpson ER. 1998. Characterization of mice deficient in aromatase (ArKO) because of targeted disruption of the cyp19 gene. Proc Natl Acad Sci U.S.A. 95(12):6965–6970.
  • Fujimoto Y, Tanaka SS, Yamaguchi YL, Kobayashi H, Kuroki S, Tachibana M, Shinomura M, Kanai Y, Morohashi K, Kawakami K, et al. 2013. Homeoproteins six1 and six4 regulate male sex determination and mouse gonadal development. Dev Cell. 26(4):416–430.
  • Gottlieb B, Beitel LK, Nadarajah A, Paliouras M, Trifiro M. 2012. The androgen receptor gene mutations database: 2012 update. Hum Mutat. 33(5):887–894.
  • Gu S, Honisch S, Kounenidakis M, Alkahtani S, Alarifi S, Alevizopoulos K, Stournaras C, Lang F. 2014. Membrane androgen receptor down-regulates c-src-activity and beta-catenin transcription and triggers GSK-3beta-phosphorylation in colon tumor cells. Cell Physiol Biochem. 34(4):1402–1412.
  • Hackel C, Oliveira LE, Ferraz LF, Tonini MM, Silva DN, Toralles MB, Stuchi-Perez EG, Guerra-Junior G. 2005. New mutations, hotspots, and founder effects in Brazilian patients with steroid 5alpha-reductase deficiency type 2. J Mol Med. 83(7):569–576.
  • Hamamy H. 2012. Consanguineous marriages: preconception consultation in primary health care settings. J Community Genet. 3(3):185–192.
  • Hernandez A. 2018. Thyroid hormone role and economy in the developing testis. Vitam Horm. 106:473–500.
  • Hoffmann R. 2007. Using the iHOP information resource to mine the biomedical literature on genes, proteins, and chemical compounds. Curr Protoc Bioinf. 1:20:1.16.1-1.16.16.
  • Holterhus PM, Werner R, Hoppe U, Bassler J, Korsch E, Ranke MB, Dorr HG, Hiort O. 2005. Molecular features and clinical phenotypes in androgen insensitivity syndrome in the absence and presence of androgen receptor gene mutations. J Mol Med. 83(12):1005–1013.
  • Hughes IA, Houk C, Ahmed SF, Lee PA, Group LC, Group EC. 2006. Consensus statement on management of intersex disorders. Arch Dis Child. 91(7):554–563.
  • Jaskelioff M, Muller FL, Paik JH, Thomas E, Jiang S, Adams AC, Sahin E, Kost-Alimova M, Protopopov A, Cadinanos J, et al. 2011. Telomerase reactivation reverses tissue degeneration in aged telomerase-deficient mice. Nature. 469(7328):102–106.
  • Jia W, Zheng D, Zhang L, Li C, Zhang X, Wang F, Guan Q, Fang L, Zhao J, Xu C. 2018. Clinical and molecular characterization of 5alpha-reductase type 2 deficiency due to mutations (p.Q6X, p.R246Q) in SRD5A2 gene. Endocr J. 65(6):645–655.
  • Joshi R, Das D, Tamhankar P, Shaikh S. 2014. Phenotypic variability in congenital lipoid adrenal hyperplasia. Indian Pediatr. 51(5):399–400.
  • Kalfa N, Philibert P, Werner R, Audran F, Bashamboo A, Lehors H, Haddad M, Guys JM, Reynaud R, Alessandrini P, et al. 2013. Minor hypospadias: the “tip of the iceberg” of the partial androgen insensitivity syndrome. PLoS ONE. 8(4):e61824.
  • Kanehisa M, Furumichi M, Tanabe M, Sato Y, Morishima K. 2017. KEGG: new perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res. 45(D1):D353–D361.
  • Kaplan FS, Kobori JA, Orellana C, Calvo I, Rosello M, Martinez F, Lopez B, Xu M, Pignolo RJ, Shore EM, et al. 2015. Multi-system involvement in a severe variant of fibrodysplasia ossificans progressiva (ACVR1 c.772G>A; R258G): A report of two patients. Am J Med Genet A. 167A(10):2265–2271.
  • Khadilkar VV, Mangtani HR, Jahagirdar RR, Khatod KA, Phadke ND, Deepa PS, Khadilkar AV. 2013. Entire DAX1 gene deletion in an Indian boy with adrenal hypoplasia congenita. Indian J Pediatr. 80(8):631–635.
  • Ko JM, Cheon CK, Kim GH, Kim SH, Kim KS, Yoo HW. 2010. Clinical characterization and analysis of the SRD5A2 gene in six Korean patients with 5alpha-reductase type 2 deficiency. Horm Res Paediatr. 73(1):41–48.
  • Kota SK, Gayatri K, Kota SK, Jammula S. 2013. Genetic analysis of a family with complete androgen insensitivity syndrome. Indian J Hum Genet. 19(3):355–357.
  • Kotlyar M, Pastrello C, Pivetta F, Lo Sardo A, Cumbaa C, Li H, Naranian T, Niu Y, Ding Z, Vafaee F, et al. 2015. In silico prediction of physical protein interactions and characterization of interactome orphans. Nat Methods. 12(1):79–84.
  • Krawczak M, Cooper DN. 1991. Gene deletions causing human genetic disease: mechanisms of mutagenesis and the role of the local DNA sequence environment. Hum Genet. 86(5):425–441.
  • Kulshreshtha B, Philibert P, Eunice M, Audran F, Paris F, Khurana ML, Ammini AC, Charles S. 2009a. Phenotype, hormonal profile and genotype of subjects with partial androgen insensitivity syndrome: report of a family with four adult males and one child with disorder of sexual differentiation. Andrologia. 41(4):257–263.
  • Kulshreshtha B, Philibert P, Eunice M, Khandelwal SK, Mehta M, Audran F, Paris F, Sultan C, Ammini AC. 2009b. Apparent male gender identity in a patient with complete androgen insensitivity syndrome. Arch Sex Behav. 38(6):873–875.
  • Lee CY, Lam CW, Shek CC. 2003. Steroid 5alpha-reductase 2 deficiency in two generations of a non-consanguineous Chinese family. J Pediatr Endocrinol Metab. 16(8):1197–1201.
  • Li B, Thrasher JB, Terranova P. 2015. Glycogen synthase kinase-3: a potential preventive target for prostate cancer management. Urol Oncol. 33(11):456–463.
  • Liu H, Yang Y, Zhang L, Liang R, Ge RS, Zhang Y, Zhang Q, Xiang Q, Huang Y, Su Z. 2014. Basic fibroblast growth factor promotes stem Leydig cell development and inhibits LH-stimulated androgen production by regulating microRNA expression. J Steroid Biochem Mol Biol. 144(Pt B):483–491.
  • Lobaccaro JM, Lumbroso S, Poujol N, Georget V, Brinkmann AO, Malpuech G, Sultan C. 1995. Complete androgen insensitivity syndrome due to a new frameshift deletion in exon 4 of the androgen receptor gene: functional analysis of the mutant receptor. Mol Cell Endocrinol. 111(1):21–28.
  • Loukola A, Chadha M, Penn SG, Rank D, Conti DV, Thompson D, Cicek M, Love B, Bivolarevic V, Yang Q, et al. 2004. Comprehensive evaluation of the association between prostate cancer and genotypes/haplotypes in CYP17A1, CYP3A4, and SRD5A2. Eur J Hum Genet. 12(4):321–332.
  • Ma P, Pan H, Montgomery RL, Olson EN, Schultz RM. 2012. Compensatory functions of histone deacetylase 1 (HDAC1) and HDAC2 regulate transcription and apoptosis during mouse oocyte development. Proc Natl Acad Sci U.S.A. 109(8):E481–489.
  • Machado AZ, Da Silva TE, Frade Costa EM, Dos Santos MG, Nishi MY, Brito VN, Mendonca BB, Domenice S. 2012. Absence of inactivating mutations and deletions in the DMRT1 and FGF9 genes in a large cohort of 46,XY patients with gonadal dysgenesis. Eur J Med Genet. 55(12):690–694.
  • MacLean HE, Ball EM, Rekaris G, Warne GL, Zajac JD. 2004. Novel androgen receptor gene mutations in Australian patients with complete androgen insensitivity syndrome. Hum Mutat. 23(3):287.
  • Mazen I, Soliman H, El-Gammal M, Torky A, Mekkawy M, Abdel-Hamid MS, Essawi M. 2014. A novel mutation (c.2735_2736delTC) in the androgen receptor gene in 46,XY females with complete androgen insensitivity syndrome in an Egyptian family. Horm Res Paediatr. 82(6):411–414.
  • McCann-Crosby B, Mansouri R, Dietrich JE, McCullough LB, Sutton VR, Austin EG, Schlomer B, Roth DR, Karaviti L, Gunn S, et al. 2014. State of the art review in gonadal dysgenesis: challenges in diagnosis and management. Int J Pediatr Endocrinol. 2014(1):4.
  • Mendonca BB, Domenice S, Arnhold IJ, Costa EM. 2009. 46,XY disorders of sex development (DSD). Clin Endocrinol (Oxf). 70(2):173–187.
  • Mills RE, Pittard WS, Mullaney JM, Farooq U, Creasy TH, Mahurkar AA, Kemeza DM, Strassler DS, Ponting CP, Webber C, et al. 2011. Natural genetic variation caused by small insertions and deletions in the human genome. Genome Res. 21(6):830–839.
  • Modi J, Modi P, Pal B, Kumar S. 2015. Bilateral Wilms’ tumors in an infant with Denys-Drash syndrome and rarely seen truncation mutation in the WT1 gene-exon 6. J Indian Assoc Pediatr Surg. 20(4):197–198.
  • Moerman P, Fryns JP, van der Steen K, Kleczkowska A, Lauweryns J. 1988. The pathology of trisomy 13 syndrome. A study of 12 cases. Hum Genet. 80(4):349–356.
  • Murta D, Batista M, Silva E, Trindade A, Henrique D, Duarte A, Lopes-da-Costa L. 2013. Dynamics of Notch pathway expression during mouse testis post-natal development and along the spermatogenic cycle. PLoS ONE. 8(8):e72767.
  • Nagaraja MR, Rastogi A, Raman R, Gupta DK, Singh SK. 2009. Mutational analysis of the androgen receptor gene in two Indian families with partial androgen insensitivity syndrome. J Pediatr Endocrinol Metab. 22(12):1169–1173.
  • Nagaraja MR, Rastogi A, Raman R, Gupta DK, Singh SK. 2010. Molecular diagnosis of 46,XY DSD and identification of a novel 8 nucleotide deletion in exon 1 of the SRD5A2 gene. J Pediatr Endocrinol Metab. 23(4):379–385.
  • Nicoletti A, Baldazzi L, Balsamo A, Barp L, Pirazzoli P, Gennari M, Radetti G, Cacciari E, Cicognani A. 2005. SRD5A2 gene analysis in an Italian population of under-masculinized 46,XY subjects. Clin Endocrinol (Oxf). 63(4):375–380.
  • Nie M, Zhou Q, Mao J, Lu S, Wu X. 2011. Five novel mutations of SRD5A2 found in eight Chinese patients with 46,XY disorders of sex development. Mol Hum Reprod. 17(1):57–62.
  • Nordenskjold A, Ivarsson SA. 1998. Molecular characterization of 5 alpha-reductase type 2 deficiency and fertility in a Swedish family. J Clin Endocrinol Metab. 83(9):3236–3238.
  • Norling A, Linden Hirschberg A, Iwarsson E, Persson B, Wedell A, Barbaro M. 2013. Novel candidate genes for 46,XY gonadal dysgenesis identified by a customized 1 M array-CGH platform. Eur J Med Genet. 56(12):661–668.
  • Ogata T, Laporte J, Fukami M. 2009. MAMLD1 (CXorf6): a new gene involved in hypospadias. Horm Res. 71(5):245–252.
  • Paliwal P, Sharma A, Birla S, Kriplani A, Khadgawat R, Sharma A. 2011. Identification of novel SRY mutations and SF1 (NR5A1) changes in patients with pure gonadal dysgenesis and 46,XY karyotype. Mol Hum Reprod. 17(6):372–378.
  • Panda B, Rao L, Tosh D, Dixit H, Padmalatha V, Kanakavalli M, Raseswari T, Deenadayal M, Gupta N, Chakrabarty B, et al. 2011. Germline study of AR gene of Indian women with ovarian failure. Gynecol Endocrinol. 27(8):572–578.
  • Paul R. 1965. Problems of psycho-sexual orientation. Guy’s Hosp Rep. 114(3):333–336.
  • Pedram A, Razandi M, Lewis M, Hammes S, Levin ER. 2014. Membrane-localized estrogen receptor alpha is required for normal organ development and function. Dev Cell. 29(4):482–490.
  • Puverel S, Kiris E, Singh S, Klarmann KD, Coppola V, Keller JR, Tessarollo L. 2016. RanBPM (RanBP9) regulates mouse c-kit receptor level and is essential for normal development of bone marrow progenitor cells. Oncotarget. 7(51):85109–85123.
  • Qian MX, Pang Y, Liu CH, Haratake K, Du BY, Ji DY, Wang GF, Zhu QQ, Song W, Yu Y, et al. 2013. Acetylation-mediated proteasomal degradation of core histones during DNA repair and spermatogenesis. Cell. 153(5):1012–1024.
  • Rajender S, Gupta NJ, Chakrabarty B, Singh L, Thangaraj K. 2009. Ala 586 Asp mutation in androgen receptor disrupts transactivation function without affecting androgen binding. Fertil Steril. 91(3):933 e923–938.
  • Rajender S, Gupta NJ, Chakrabarty B, Singh L, Thangaraj K. 2013. L712V mutation in the androgen receptor gene causes complete androgen insensitivity syndrome due to severe loss of androgen function. Steroids. 78(12–13):1288–1292.
  • Rajender S, Pooja S, Gupta NJ, Chakrabarty B, Singh L, Thangaraj K. 2011. G708E mutation in the androgen receptor results in complete loss of androgen function. J Androl. 32(2):193–198.
  • Rajender S, Rajani V, Gupta NJ, Chakravarty B, Singh L, Thangaraj K. 2006. SRY-negative 46,XX male with normal genitals, complete masculinization and infertility. Mol Hum Reprod. 12(5):341–346.
  • Rao TS, Asha MR, Sambamurthy K, Rao KS. 2009. Consanguinity: still a challenge. Indian J Psychiatry. 51(1):3–5.
  • Ratan SK, Sharma A, Kapoor S, Polipalli SK, Dubey D, Mishra TK, Sinha SK, Agarwal SK. 2016. Polymorphism of 3ʹ UTR of MAMLD1 gene is also associated with increased risk of isolated hypospadias in Indian children: a preliminary report. Pediatr Surg Int. 32(5):515–524.
  • Rey RA, Belville C, Nihoul-Fekete C, Michel-Calemard L, Forest MG, Lahlou N, Jaubert F, Mowszowicz I, David M, Saka N, et al. 1999. Evaluation of gonadal function in 107 intersex patients by means of serum antimullerian hormone measurement. J Clin Endocrinol Metab. 84(2):627–631.
  • Russo D, Blanco M, Falke G, Rocca Rivarola M, Seller R, Puigdevall JC, Bergada C. 2006. Pure gonad dysgenesia or Swyer sindrome. A case report having tumoral development: melanoma. Cir Pediatr. 19(4):244–246.
  • Sahu R, Boddula R, Sharma P, Bhatia V, Greaves R, Rao S, Desai M, Wakhlu A, Phadke S, Shukla M, et al. 2009. Genetic analysis of the SRD5A2 gene in Indian patients with 5alpha-reductase deficiency. J Pediatr Endocrinol Metab. 22(3):247–254.
  • Saranya B, Bhavani G, Arumugam B, Jayashankar M, Santhiya ST. 2016. Three novel and two known androgen receptor gene mutations associated with androgen insensitivity syndrome in sex-reversed XY female patients. J Genet. 95(4):911–921.
  • Sata F, Kurahashi N, Ban S, Moriya K, Tanaka KD, Ishizuka M, Nakao H, Yahata Y, Imai H, Kakizaki H, et al. 2010. Genetic polymorphisms of 17 beta-hydroxysteroid dehydrogenase 3 and the risk of hypospadias. J Sex Med. 7(8):2729–2738.
  • Sfez-Yaiche A, Sulmont V. 2000. Evaluation approach in sexual ambiguity: reims experience from a retrospective study. Arch Pediatr. 7(Suppl 2):382s–384s.
  • Shabir I, Khurana ML, Joseph AA, Eunice M, Mehta M, Ammini AC. 2015. Phenotype, genotype and gender identity in a large cohort of patients from India with 5alpha-reductase 2 deficiency. Andrology. 3(6):1132–1139.
  • Shahid M, Dhillion VS, Jain N, Hedau S, Diwakar S, Sachdeva P, Batra S, Das BC, Husain SA. 2004. Two new novel point mutations localized upstream and downstream of the HMG box region of the SRY gene in three Indian 46,XY females with sex reversal and gonadal tumour formation. Mol Hum Reprod. 10(7):521–526.
  • Shahid M, Dhillon VS, Hussain Z, Masa JF, Aslam M, Raish M, Ahmad A, Khan NJ, Prasad S, Batra S, et al. 2008. Analysis of the SRY gene in two sex-reversed XY sisters identifies two new novel point mutations in the high mobility group box domain. Fertil Steril. 90(4):1199e1191–1198.
  • Sharma V, Singh R, Thangaraj K, Jyothy A. 2011. A novel Arg615Ser mutation of androgen receptor DNA-binding domain in three 46,XY sisters with complete androgen insensitivity syndrome and bilateral inguinal hernia. Fertil Steril. 95(2):804 e819–821.
  • Sharma V, Thangaraj K, Jyothy A. 2014a. A novel androgen receptor gene mutation in a patient with congenital adrenal hyperplasia associated with penoscrotal hypospadias. Transl Res. 164(2):149–152.
  • Sharma V, Thangaraj K, Jyothy A. 2014b. A novel insertion-induced frameshift mutation of the androgen receptor gene in a patient with primary amenorrhea. Meta Gene. 2:11–15.
  • Shulman ST. 2012. Adolescents and sexual ambiguity. Pediatr Ann. 41(4):129–130.
  • Siggers P, Carre GA, Bogani D, Warr N, Wells S, Hilton H, Esapa C, Hajihosseini MK, Greenfield A. 2014. A novel mouse Fgfr2 mutant, hobbyhorse (hob), exhibits complete XY gonadal sex reversal. PLoS ONE. 9(6):e100447.
  • Singh R, Shastry PK, Rasalkar AA, Singh L, Thangaraj K. 2006. A novel androgen receptor mutation resulting in complete androgen insensitivity syndrome and bilateral Leydig cell hyperplasia. J Androl. 27(4):510–516.
  • Singh R, Singh P, Gupta NJ, Chakrabarty B, Singh L, Thangaraj K. 2010. C601S mutation in the androgen receptor results in partial loss of androgen function. J Steroid Biochem Mol Biol. 122(5):359–363.
  • Sinha A, Sharma S, Gulati A, Sharma A, Agarwala S, Hari P, Bagga A. 2010. Frasier syndrome: early gonadoblastoma and cyclosporine responsiveness. Pediatr Nephrol. 25(10):2171–2174.
  • Smith CA, McClive PJ, Western PS, Reed KJ, Sinclair AH. 1999. Conservation of a sex-determining gene. Nature. 402(6762):601–602.
  • Stenson PD, Mort M, Ball EV, Evans K, Hayden M, Heywood S, Hussain M, Phillips AD, Cooper DN. 2017. The human gene mutation database: towards a comprehensive repository of inherited mutation data for medical research, genetic diagnosis and next-generation sequencing studies. Hum Genet. 136(6):665–677.
  • Sudhakar DVS, Nizamuddin S, Manisha G, Devi JR, Gupta NJ, Chakravarthy BN, Deenadayal M, Singh L, Thangaraj K. 2018. NR5A1 mutations are not associated with male infertility in Indian men. Andrologia. 50(3):e12931.
  • Szklarczyk D, Franceschini A, Wyder S, Forslund K, Heller D, Huerta-Cepas J, Simonovic M, Roth A, Santos A, Tsafou KP, et al. 2015. STRING v10: protein-protein interaction networks, integrated over the tree of life. Nucleic Acids Res. 43(Database issue):D447–452.
  • Thiele B, Weidemann W, Schnabel D, Romalo G, Schweikert HU, Spindler KD. 1999. Complete androgen insensitivity caused by a new frameshift deletion of two base pairs in exon 1 of the human androgen receptor gene. J Clin Endocrinol Metab. 84(5):1751–1753.
  • Thigpen AE, Davis DL, Gautier T, Imperato-McGinley J, Russell DW. 1992a. Brief report: the molecular basis of steroid 5 alpha-reductase deficiency in a large Dominican kindred. N Engl J Med. 327(17):1216–1219.
  • Thigpen AE, Davis DL, Milatovich A, Mendonca BB, Imperato-McGinley J, Griffin JE, Francke U, Wilson JD, Russell DW. 1992b. Molecular genetics of steroid 5 alpha-reductase 2 deficiency. J Clin Invest. 90(3):799–809.
  • van Dam S, Vosa U, van der Graaf A, Franke L, de Magalhaes JP. 2018. Gene co-expression analysis for functional classification and gene-disease predictions. Brief Bioinformatics. 19(4):575–592.
  • Vanorny DA, Prasasya RD, Chalpe AJ, Kilen SM, Mayo KE. 2014. Notch signaling regulates ovarian follicle formation and coordinates follicular growth. Mol Endocrinol. 28(4):499–511.
  • Vasu VR, Saranya B, Jayashankar M, Munirajan AK, Santhiya ST. 2012. A novel splice site and two known mutations of androgen receptor gene in sex-reversed XY phenotype. Genet Test Mol Biomarkers. 16(7):749–755.
  • Vasudevan L, Joshi R, Das DK, Rao S, Sanghavi D, Babu S, Tamhankar PM. 2013. Identification of novel mutations in STAR gene in patients with lipoid congenital adrenal hyperplasia: a first report from India. J Clin Res Pediatr Endocrinol. 5(2):121–124.
  • Verma N, Jain V, Birla S, Jain R, Sharma A. 2012. Growth and hormonal profile from birth to adolescence of a girl with aromatase deficiency. J Pediatr Endocrinol Metab. 25(11–12):1185–1190.
  • Vilchis F, Mendez JP, Canto P, Lieberman E, Chavez B. 2000. Identification of missense mutations in the SRD5A2 gene from patients with steroid 5alpha-reductase 2 deficiency. Clin Endocrinol (Oxf). 52(3):383–387.
  • Vilela ML, Willingham E, Buckley J, Liu BC, Agras K, Shiroyanagi Y, Baskin LS. 2007. Endocrine disruptors and hypospadias: role of genistein and the fungicide vinclozolin. Urology. 70(3):618–621.
  • Wang F, Pan J, Liu Y, Meng Q, Lv P, Qu F, Ding GL, Klausen C, Leung PC, Chan HC, et al. 2015a. Alternative splicing of the androgen receptor in polycystic ovary syndrome. Proc Natl Acad Sci U.S.A. 112(15):4743–4748.
  • Wang J, Liu S, Peng L, Dong Q, Bao R, Lv Q, Tang M, Hu C, Li G, Liang S, et al. 2015b. Notch signaling pathway regulates progesterone secretion in murine luteal cells. Reprod Sci. 22(10):1243–1251.
  • Wang TR, Yan LY, Yan J, Lu CL, Xia X, Yin TL, Zhu XH, Gao JM, Ding T, Hu WH, et al. 2014. Basic fibroblast growth factor promotes the development of human ovarian early follicles during growth in vitro. Hum Reprod. 29(3):568–576.
  • Wang Y, Li Q, Xu J, Liu Q, Wang W, Lin Y, Ma F, Chen T, Li S, Shen Y. 2004. Mutation analysis of five candidate genes in Chinese patients with hypospadias. Eur J Hum Genet. 12(9):706–712.
  • Werner R, Holterhus PM, Binder G, Schwarz HP, Morlot M, Struve D, Marschke C, Hiort O. 2006. The A645D mutation in the hinge region of the human androgen receptor (AR) gene modulates AR activity, depending on the context of the polymorphic glutamine and glycine repeats. J Clin Endocrinol Metab. 91(9):3515–3520.
  • Wigley CW, Prihoda JS, Mowszowicz I, Mendonca BB, New MI, Wilson JD, Russell DW. 1994. Natural mutagenesis study of the human steroid 5α-reductase 2 isozyme. Biochemistry. 33(5):1265–1270.
  • Wilson JD, Griffin JE, Russell DW. 1993. Steroid 5 alpha-reductase 2 deficiency. Endocr Rev. 14(5):577–593.
  • Witters I, Moerman P, Muenke M, Van Assche FA, Devriendt K, Legius E, Van Schoubroeck D, Fryns JP. 2001. Semilobar holoprosencephaly in a 46,XY female fetus. Prenat Diagn. 21(10):839–841.
  • Xiao PJ, Hu L, Li J, Lin W, Chen X, Xu P. 2007. NSSR1 is regulated in testes development and cryptorchidism and promotes the exon 5-included splicing of CREB transcripts. Mol Reprod Dev. 74(11):1363–1372.
  • Xu J, Li J, Wang H, Wang G, Chen J, Huang P, Cheng J, Gan L, Wang Z, Cai Y. 2015. A novel SMAD family protein, SMAD9 is involved in follicular initiation and changes egg yield of geese via synonymous mutations in exon1 and intron2. Mol Biol Rep. 42(1):289–302.
  • Yang Y, Wang BA, Guo QH, Dou JT, Lv ZH, Ba JM, Lu JM, Pan CY, Mu YM. 2012. Clinical and genetic analysis of three Chinese patients with steroid 5alpha-reductase type 2 deficiency. J Pediatr Endocrinol Metab. 25(11–12):1077–1082.
  • Yoon H, Jang H, Kim EY, Moon S, Lee S, Cho M, Cho HJ, Ko JJ, Chang EM, Lee KA, et al. 2018. Knockdown of PRKAR2B results in the failure of oocyte maturation. Cell Physiol Biochem. 45(5):2009–2020.
  • Young JC, Wakitani S, Loveland KL. 2015. TGF-beta superfamily signaling in testis formation and early male germline development. Semin Cell Dev Biol. 45:94–103.
  • Yuan S, Meng L, Zhang Y, Tu C, Du J, Li W, Liang P, Lu G, Tan YQ. 2017. Genotype-phenotype correlation and identification of two novel SRD5A2 mutations in 33 Chinese patients with hypospadias. Steroids. 125:61–66.
  • Zhou CK, Stanczyk FZ, Hafi M, Veneroso CC, Lynch B, Falk RT, Niwa S, Emanuel E, Gao YT, Hemstreet GP, et al. 2017. Circulating and intraprostatic sex steroid hormonal profiles in relation to male pattern baldness and chest hair density among men diagnosed with localized prostate cancers. Prostate. 77(16):1573–1582.
  • Zhou J, Fu BQ. 2018. The research on gene-disease association based on text-mining of PubMed. BMC Bioinformatics. 19(1):37.
  • Zhu H, Liu W, Han B, Fan M, Zhao S, Wang H, Lu Y, Pan C, Chen F, Chen M, et al. 2014. Phenotypic and molecular characteristics in eleven Chinese patients with 5alpha-reductase Type 2 deficiency. Clin Endocrinol (Oxf). 81(5):711–720.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.